HUTCHMED (China) Limited (0013.HK)

HKD 23.0

(-0.22%)

Total Liabilities Summary of HUTCHMED (China) Limited

  • HUTCHMED (China) Limited's latest annual total liabilities in 2023 was 536.38 Million USD , up 36.63% from previous year.
  • HUTCHMED (China) Limited's latest quarterly total liabilities in 2024 Q1 was 508.85 Million USD , down -5.13% from previous quarter.
  • HUTCHMED (China) Limited reported annual total liabilities of 392.57 Million USD in 2022, up 17.84% from previous year.
  • HUTCHMED (China) Limited reported annual total liabilities of 333.14 Million USD in 2021, up 62.38% from previous year.
  • HUTCHMED (China) Limited reported quarterly total liabilities of 508.85 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported quarterly total liabilities of 497.48 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of HUTCHMED (China) Limited (2023 - 2005)

Historical Annual Total Liabilities of HUTCHMED (China) Limited (2023 - 2005)

Year Total Liabilities Total Liabilities Growth
2023 536.38 Million USD 36.63%
2022 392.57 Million USD 17.84%
2021 333.14 Million USD 62.38%
2020 205.16 Million USD 34.79%
2019 152.21 Million USD 26.99%
2018 119.86 Million USD 6.11%
2017 112.96 Million USD -18.36%
2016 138.37 Million USD 8.55%
2015 127.47 Million USD 28.69%
2014 99.05 Million USD 22.55%
2013 80.83 Million USD -35.76%
2012 125.81 Million USD 7.13%
2011 117.44 Million USD 28.89%
2010 91.11 Million USD 73.71%
2009 52.45 Million USD 56.43%
2008 33.53 Million USD 11.93%
2007 29.95 Million USD 29.89%
2006 23.06 Million USD -74.63%
2005 90.89 Million USD 0.0%

Peer Total Liabilities Comparison of HUTCHMED (China) Limited

Name Total Liabilities Total Liabilities Difference
Pak Fah Yeow International Limited 142.28 Million HKD -276.988%
Grand Pharmaceutical Group Limited 7.24 Billion HKD 92.596%
Extrawell Pharmaceutical Holdings Limited 170.4 Million HKD -214.768%
Wai Yuen Tong Medicine Holdings Limited 709.65 Million HKD 24.416%
Qianhai Health Holdings Limited 94 Million HKD -470.605%
Lee's Pharmaceutical Holdings Limited 930.06 Million HKD 42.328%
Essex Bio-Technology Limited 903.78 Million HKD 40.651%
Tongfang Kontafarma Holdings Limited 665.38 Million HKD 19.388%
PuraPharm Corporation Limited 689.65 Million HKD 22.224%
SSY Group Limited 4.49 Billion HKD 88.064%
JBM (Healthcare) Limited 366.75 Million HKD -46.253%
Jacobson Pharma Corporation Limited 1.09 Billion HKD 50.813%
China Resources Pharmaceutical Group Limited 168.46 Billion HKD 99.682%